Product ID |
Product Name |
CAS# |
Purity |
Y3258229 |
2-[5-(2-chlorophenyl)-1H-1,2,3,4-tetrazol-1-yl]aceticacid |
131648-21-0 |
95% |
Y3138729 |
2-(3-Cyclopropylthiophen-2-yl)acetic acid |
1369155-13-4 |
95% |
Y3138809 |
Lithium 2-(2,1-benzoxazol-3-yl)acetate |
2751611-09-1 |
95% |
Y3138737 |
6-Fluoro-1,2-benzisoxazole-3-acetic acid |
66233-72-5 |
95% |
Y3294412 |
Lithium 7-amino-[1,2,4]triazolo[1,5-a]pyrimidine-6-carboxylate |
2241140-74-7 |
95% |
Y3136813 |
2-(oxan-4-yl)propanal |
1547031-09-3 |
95% |
Y3313354 |
Cochliodone A |
1072931-48-6 |
95% |
Y3137122 |
(1S)-1-(2,5-dibromophenyl)ethan-1-ol |
2227896-22-0 |
95% |
Y3136798 |
2-(difluoromethyl)-1-methylpiperazine |
1780451-86-6 |
95% |
Y3136827 |
2-(1-ethyl-3-methyl-1H-pyrazol-4-yl)acetic acid |
1314907-39-5 |
95% |
Y1333495 |
2',4,4',6-Tetrachloro[1,1'-biphenyl]-3-carboxylic acid |
1141365-29-8 |
95%+ |
Y3136812 |
(7-methyl-1-benzofuran-5-yl)boronic acid |
254886-15-2 |
95% |
Y3296868 |
rac-tert-butyl (1R,5S)-1-formyl-5-(trifluoromethyl)-3-azabicyclo[3.1.0]hexane-3-carboxylate, cis |
2138056-43-4 |
91% |
Y3136926 |
4-(azetidin-3-yl)-3-(3-methyl-1,2,4-oxadiazol-5-yl)morpholine dihydrochloride |
2126162-34-1 |
92% |
Y3314121 |
N1-(7-nitrobenzo[c][1,2,5]oxadiazol-4-yl)ethane-1,2-diamine |
190324-44-8 |
95% |
Y3136808 |
tert-butyl 3-(hydroxyimino)cyclobutane-1-carboxylate |
2135785-57-6 |
95% |
Y3136671 |
tert-butyl 4-bromo-2,3-difluorobenzoate |
2684295-19-8 |
95% |
Y3286861 |
dTAG-47 |
2265886-81-3 |
99% |
Y3315406 |
3-cyanoazetidine-1-sulfonamide |
1494596-65-4 |
95% |
Y3317949 |
3-Amino-2-butanol hydrochloride |
131744-08-6 |
95% |
Y1338603 |
4-[6-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl]-2-nitroaniline |
23623-05-4 |
97% |
Y3289108 |
tert-Butyl (1R,2R,5S)-2-(hydroxymethyl)-3,8-diazabicyclo[3.2.1]octane-3-carboxylate |
2679950-12-8 |
95% |
Y3285857 |
4-(piperidine-4-carbonyl)-1-[4-(trifluoromethoxy)phenyl]-1H-pyrazol-5-amine |
1381459-14-8 |
99% |
Y3308469 |
4-Chloro-N-(2,4-dinitrophenyl)butanamide hydrate |
302966-93-4 |
97% |
Y3307157 |
Tafetinib |
1032265-57-8 |
96% |
Y3285732 |
AT791 |
1219962-49-8 |
98% |
Y3318341 |
3-Fluoro-5-(piperidin-1-yl)phenylboronic acid |
2225155-90-6 |
97% |
Y3310753 |
4'-Bromo-3'-fluoro-2'-iodoacetophenone |
1824056-42-9 |
95% |
Y3318174 |
SR-717 free acid |
2375420-34-9 |
97% |
Y1343239 |
LY367385 hydrochloride |
2829282-00-8 |
98% |
Y3248084 |
TERT-BUTYL 2-CYCLOPROPYL-6-(3,5-DIMETHYLISOXAZOL-4-YL)-4-(TETRAHYDROFURAN-2-CARBONYL)-1H-BENZO[D]IMIDAZOLE-1-CARBOXYLATE |
1637773-87-5 |
97% |
Y3255635 |
N-(1-((6AR,8R,9AR)-9-CYANO-9-HYDROXY-2,2,4,4-TETRAISOPROPYLTETRAHYDRO-6H-FURO[3,2-F][1,3,5,2,4]TRIOXADISILOCIN-8-YL)-2-OXO-1,2-DIHYDROPYRIMIDIN-4-YL)ACETAMIDE |
1194441-31-0 |
97% |
Y1344480 |
(6-(DIMETHYLAMINO)-5-(METHOXYCARBONYL)PYRIDIN-3-YL)BORONIC ACID PINACOL ESTER |
2304634-88-4 |
95% |
Y3136292 |
3-Bromopyridine-4-sulfonyl fluoride |
2229049-79-8 |
95% |
Y1338022 |
Tos-PEG2-THP |
69502-32-5 |
95% |
Y1334099 |
Benzyl-PEG4-Boc |
2484091-04-3 |
98% |
Y3133904 |
ETHYL 6-AMINO-3-CHLORO-2-FLUOROBENZOATE |
869333-32-4 |
95% |
Y1342756 |
AS-85 |
2323623-80-7 |
98% |
Y1336702 |
Benzyl-PEG4-THP |
1027926-86-8 |
95% |
Y3133906 |
Norbiotinamine |
173401-47-3 |
99% |
Y1344449 |
EMT inhibitor-2 |
2232228-60-1 |
99% |
Y3133917 |
DDR1-IN-6 |
2416021-47-9 |
95% |
Y3145882 |
(4-(TRIFLUOROMETHYL)THIOPHEN-2-YL)METHANOL |
1447914-79-5 |
95% |
Y3146793 |
(S)-3-((TERT-BUTYLDIMETHYLSILYL)OXY)-1,1-DIFLUOROPROPAN-2-AMINE |
925422-95-3 |
95% |
Y3131503 |
tert-butyl N-(1-carbamothioylethyl)-N-methylcarbamate |
473541-40-1 |
95% |
Y3131506 |
1-(2-bromoethyl)-4-tert-butylbenzene |
56829-61-9 |
95% |
Y3131505 |
4,4,4-trifluoro-3-(1,2-oxazol-3-yl)butanoic acid |
2098053-64-4 |
95% |
Y3306695 |
2'-Bromo-5'-chloro-4'-fluoroacetophenone |
2092325-31-8 |
95% |
Y3131771 |
3,3-difluoropropanethioamide |
1178490-19-1 |
95% |
Y3131619 |
2-(2-chloro-1,3-thiazol-5-yl)-2,2-difluoroacetic acid |
2228654-04-2 |
95% |
Y3131096 |
1-(5-chloro-2-methoxyphenyl)cyclopropane-1-carboxylic acid |
1039952-36-7 |
95% |
Y3131094 |
3-(6-chloropyridin-3-yl)-1-methyl-1H-pyrazol-5-amine |
2228873-36-5 |
95% |
Y1336651 |
4-[(Benzo[b]thien-3-ylcarbonyl)[2-(4-chlorophenyl)ethyl]amino]-N-(2,4-difluorophenyl)-1-piperidinecarboxamide |
1092847-21-6 |
95%+ |
Y3131102 |
4-(morpholin-4-yl)benzene-1-sulfonamide |
91619-25-9 |
95% |
Y3131093 |
5-Cyclobutyl-1,2-oxazol-4-amine hydrochloride |
1080059-86-4 |
95% |
Y3131103 |
rac-tert-butyl (3R,4S)-3-amino-4-[4-(trifluoromethyl)phenyl]piperidine-1-carboxylate, cis |
2230807-27-7 |
95% |
Y3131489 |
2,4-difluoro-6-methoxyanilinehydrochloride |
2375274-55-6 |
95% |
Y3287057 |
2,4-Difluoro-6-methoxyaniline |
1400653-78-2 |
98% |
Y3131275 |
6-fluoroquinolin-5-ol |
1261809-05-5 |
95% |
Y3136590 |
ethyl2,5-dihydro-1H-pyrrole-3-carboxylatehydrochloride |
35957-74-5 |
95% |
Y3136586 |
7-(bromomethyl)-3-chloro-1-benzothiophene |
88415-30-9 |
95% |
Y3136596 |
methyl2-amino-[1,3]oxazolo[4,5-b]pyridine-6-carboxylate |
2092030-24-3 |
95% |
Y3136604 |
methyl2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)cyclopent-1-ene-1-carboxylate |
1449522-62-6 |
95% |
Y3136688 |
4-methoxy-4-methylcyclohexan-1-amine |
1429902-65-7 |
95% |
Y3136691 |
3-(2-methylpropoxy)cyclohexan-1-aminehydrochloride,Mixtureofdiastereomers |
2287283-98-9 |
95% |
Y3136676 |
tert-butyl (6r,9r)-9-amino-1-oxa-4-azaspiro[5.5]undecane-4-carboxylate |
2260917-54-0 |
95% |
Y3136674 |
rac-(1R,3S)-3-aminocyclohexane-1-carboxamidehydrochloride |
2307738-42-5 |
95% |
Y3138721 |
sodium 5-cyclopropyl-1-methyl-1H-1,2,4-triazole-3-carboxylate |
2624137-74-0 |
95% |
Y3138747 |
4-chloro-3,3-difluorobutanoicacid |
2167470-97-3 |
95% |
Y3138748 |
tert-butyl3-oxo-1-azaspiro[3.3]heptane-1-carboxylate |
2408964-65-6 |
95% |
Y3313696 |
6-Bromo-3-chlorodibenzofuran |
2361279-68-5 |
99% |
Y3138751 |
2-(1-(METHOXYCARBONYL)CYCLOPROPYL)ACETIC ACID |
2106639-41-0 |
95% |
Y3138853 |
3-bromo-4-methylpyridine-2-carboxylic acid |
1211541-04-6 |
95% |
Y3138846 |
N-Nitroso Duloxetine |
2680527-91-5 |
95% |
Y1335127 |
Propanol-PEG4-CH2OH |
156868-17-6 |
98% |
Y3138869 |
2-(piperidin-4-yl)pyrimidine-5-carboxylicaciddihydrochloride |
2344685-47-6 |
95% |
Y3293763 |
D-Alanine-3,3,3-d3-N-t-BOC |
177614-70-9 |
98% |
Y3291591 |
1-(2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-5-yl)piperidine-4-carbaldehyde |
2241315-66-0 |
99% |
Y3139431 |
(9R)-9-hydroxy-5H,6H,7H,8H,9H-cyclohepta[b]pyridin-5-onehydrochloride |
1397526-22-5 |
95% |
Y3139454 |
6-bromo-1,3-dimethyl-1,2-dihydropyridin-2-one |
99934-54-0 |
95% |
Y3137003 |
tert-butyl(6S)-6-(bromomethyl)-2,2-dimethylmorpholine-4-carboxylate |
2375249-44-6 |
95% |
Y3136987 |
tert-butyl(6R)-6-(bromomethyl)-2,2-dimethylmorpholine-4-carboxylate |
2375247-89-3 |
95% |
Y3137016 |
3-Fluoro-1-methyl-1H-pyrazole-4-carboxylic acid; . |
1823271-62-0 |
95% |
Y1340234 |
Methyl (3-chlorophenyl)carbamate |
2150-88-1 |
95%+ |
Y3133912 |
N-[5-(4-hydroxy-3-methylphenyl)-1-methyl-1H-imidazol-2-yl]-3-[(2-oxopyrrolidin-1-yl)methyl]benzamide |
2476158-65-1 |
95% |
Y3289864 |
1-Piperidinecarboxylic acid, 4-(4-cyanophenyl)-4-fluoro-, 1,1-dimethylethyl ester |
912556-70-8 |
95% |
Y3291789 |
Pomalidomide-PEG1-NH2-1 hydrochloride |
2380273-67-4 |
97% |
Y3133987 |
ethyl2-bromocyclobutane-1-carboxylate |
2983-89-3 |
95% |
Y3137223 |
rac-(1R,5R)-1-chloro-6,6,7,7-tetrafluoro-3-azabicyclo[3.2.0]heptane hydrochloride, cis |
2230799-62-7 |
95% |
Y3286065 |
Cu-ATSP |
68341-12-8 |
95% |
Y3310101 |
ZX-J-19J |
1352576-02-3 |
99% |
Y3137020 |
XJB-5-131 |
866404-31-1 |
95% |
Y3294619 |
Pomalidomide-C5-azide |
2434629-02-2 |
97% |
Y3297274 |
XL 188 |
2305045-76-3 |
98% |
Y3285924 |
XP-524 |
2344825-52-9 |
99% |
Y3136990 |
Valiloxibic acid |
238401-16-6 |
97% |
Y3296150 |
Tunlametinib |
1801756-06-8 |
98% |
Y3137010 |
Tigulixostat |
1287766-55-5 |
98.0% |
Y3306919 |
Thr101 |
727664-79-1 |
99% |
Y3137009 |
SRPIN803 |
380572-02-1 |
99% |